News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
430,180 Results
Type
Article (19349)
Company Profile (143)
Press Release (410688)
Multimedia
Podcasts (39)
Webinars (8)
Section
Business (129815)
Career Advice (619)
Deals (20672)
Drug Delivery (40)
Drug Development (43591)
Employer Resources (70)
FDA (9987)
Job Trends (9241)
News (205585)
Policy (15353)
Tag
Academia (1779)
Accelerated approval (3)
Adcomms (3)
Allergies (57)
Alliances (38184)
ALS (46)
Alzheimer's disease (842)
Antibody-drug conjugate (ADC) (82)
Approvals (10016)
Artificial intelligence (265)
Autoimmune disease (10)
Automation (14)
Bankruptcy (146)
Best Places to Work (7821)
BIOSECURE Act (8)
Biosimilars (28)
Biotechnology (108)
Bladder cancer (41)
Brain cancer (16)
Breast cancer (171)
Cancer (1403)
Cardiovascular disease (122)
Career advice (554)
Career pathing (16)
CAR-T (120)
Cell therapy (317)
Cervical cancer (11)
Clinical research (34530)
Collaboration (677)
Compensation (153)
Complete response letters (5)
COVID-19 (1558)
CRISPR (44)
C-suite (188)
Cystic fibrosis (68)
Data (1479)
Decentralized trials (1)
Denatured (18)
Depression (23)
Diabetes (152)
Diagnostics (5332)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (15)
Drug discovery (87)
Drug pricing (21)
Drug shortages (6)
Duchenne muscular dystrophy (47)
Earnings (44383)
Editorial (11)
Employer branding (11)
Employer resources (62)
Events (63523)
Executive appointments (526)
FDA (10799)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (579)
Gene editing (99)
Generative AI (26)
Gene therapy (210)
GLP-1 (325)
Government (1799)
Grass and pollen (2)
Guidances (44)
Healthcare (11744)
Huntington's disease (6)
IgA nephropathy (17)
Immunology and inflammation (45)
Indications (18)
Infectious disease (1646)
Inflammatory bowel disease (89)
Inflation Reduction Act (3)
Influenza (36)
Intellectual property (72)
Interviews (78)
IPO (9048)
IRA (12)
Job creations (1777)
Job search strategy (491)
Kidney cancer (6)
Labor market (14)
Layoffs (176)
Leadership (8)
Legal (3058)
Liver cancer (42)
Lung cancer (181)
Lymphoma (86)
Machine learning (6)
Management (25)
Manufacturing (202)
MASH (33)
Medical device (11878)
Medtech (11883)
Mergers & acquisitions (12022)
Metabolic disorders (340)
Multiple sclerosis (42)
NASH (6)
Neurodegenerative disease (50)
Neuropsychiatric disorders (10)
Neuroscience (1144)
NextGen: Class of 2025 (4065)
Non-profit (2400)
Now hiring (17)
Obesity (151)
Opinion (102)
Ovarian cancer (46)
Pain (59)
Pancreatic cancer (51)
Parkinson's disease (102)
Partnered (15)
Patents (167)
Patient recruitment (74)
Peanut (32)
People (40346)
Pharmaceutical (21)
Phase I (11743)
Phase II (15185)
Phase III (10870)
Pipeline (748)
Policy (49)
Postmarket research (1007)
Preclinical (5774)
Press Release (68)
Prostate cancer (66)
Psychedelics (14)
Radiopharmaceuticals (175)
Rare diseases (210)
Real estate (3795)
Recruiting (29)
Regulatory (11585)
Reports (19)
Research institute (1790)
Resumes & cover letters (88)
Rett syndrome (4)
RNA editing (2)
RSV (24)
Schizophrenia (26)
Series A (107)
Series B (59)
Service/supplier (7)
Sickle cell disease (34)
Special edition (2)
Spinal muscular atrophy (98)
Sponsored (19)
Startups (2839)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (8)
The Weekly (20)
Vaccines (383)
Venture capitalists (24)
Weight loss (66)
Women's health (20)
Worklife (4)
Date
Today (2)
Last 7 days (582)
Last 30 days (1669)
Last 365 days (21095)
2025 (6941)
2024 (22887)
2023 (26764)
2022 (36002)
2021 (38332)
2020 (36007)
2019 (30237)
2018 (22826)
2017 (22165)
2016 (20980)
2015 (24183)
2014 (17939)
2013 (14852)
2012 (15976)
2011 (16375)
2010 (14799)
Location
Africa (399)
Alabama (46)
Alaska (6)
Arizona (139)
Arkansas (12)
Asia (26688)
Australia (4711)
California (3848)
Canada (1298)
China (299)
Colorado (195)
Connecticut (175)
Delaware (69)
Europe (58701)
Florida (568)
Georgia (163)
Idaho (40)
Illinois (322)
India (13)
Indiana (191)
Iowa (5)
Japan (124)
Kansas (87)
Kentucky (10)
Louisiana (9)
Maine (56)
Maryland (542)
Massachusetts (2749)
Michigan (193)
Minnesota (282)
Mississippi (2)
Missouri (68)
Montana (25)
Nebraska (16)
Nevada (31)
New Hampshire (69)
New Jersey (1118)
New Mexico (27)
New York (1116)
North Carolina (629)
North Dakota (8)
Northern California (1651)
Ohio (141)
Oklahoma (13)
Oregon (34)
Pennsylvania (815)
Puerto Rico (11)
Rhode Island (30)
South America (604)
South Carolina (22)
South Dakota (1)
Southern California (1452)
Tennessee (70)
Texas (602)
United States (14757)
Utah (144)
Virginia (77)
Washington D.C. (18)
Washington State (388)
West Virginia (3)
Wisconsin (41)
430,180 Results for "redwood scientific technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Redwood Scientific Technologies Inc.today announced a strategic shift in its product development priorities
Redwood Scientific Technologies Inc. (OTC: RSCI) (“Redwood” or “the Company”), a pharmaceutical company, today announced a strategic shift in its product development priorities.
April 18, 2024
·
2 min read
Pharm Country
Redwood Scientific Technologies Inc. (RSCI.OTC.PK) Announces Successful S1 Registration Filing and Provides Updates on TBX FREE Clinical Trial Progress
Redwood Scientific Technologies is delighted to announce the successful filing of its S1 registration statement with the Securities and Exchange Commission (SEC).
September 18, 2023
·
1 min read
Business
Redwood Scientific Technologies Inc., Announces Partnership Agreement with Silk Road Ent., Inc., for Retail Distribution of TBX FREE and TBX VAPE FREE
Redwood Scientific Technologies Inc. (RSCI. OTC. PK) announces a partnership with Silk Road Ent., Inc. (SKRJ, OTC, PK) for retail distribution of TBX FREE and TBX VAPE FREE, its smoking cessation products.
July 19, 2023
·
1 min read
Policy
Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facility
Eyenovia, Inc. announced that the company’s facility in Redwood City, California successfully completed FDA inspection for approval as a commercial manufacturing facility.
February 13, 2024
·
5 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Editorial
Biomedical Innovation in Jeopardy as Kennedy Distorts, Denies Scientific Truths
As the Trump administration—including HHS Secretary Robert F. Kennedy Jr.—plays fast and loose with scientific studies and facts, there may be a more sinister force at play: censorship.
May 2, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Hera BioLabs Increases Scientific Transparency and Engagement With Bioz Technology
January 29, 2025
·
2 min read
Redwood Pharma presents positive results from a clinical study with RP501 against dry eye
Redwood Pharma AB (publ) announces positive results from the company’s clinical study with RP501, a medical technology self-care product being developed for the treatment of dry eye.
May 31, 2023
·
2 min read
Biotech Bay
Cytokinetics Presents Positive Results From Cohort 4 of REDWOOD-HCM and Long-Term Results From FOREST-HCM at the American College of Cardiology 72nd Annual Scientific Session
Cytokinetics, Incorporated announced that positive results from Cohort 4 of REDWOOD-HCM, a Phase 2 clinical trial of aficamten in patients with non-obstructive hypertrophic cardiomyopathy, were presented at the American College of Cardiology 72nd Annual Scientific Session.
March 4, 2023
·
11 min read
Business
Pixelgen Technologies Appoints Mostafa Ronaghi to Scientific Advisory Board
Pixelgen Technologies announced today the appointment of Mostafa Ronaghi , Ph.D., to its Scientific Advisory Board.
April 30, 2024
·
2 min read
1 of 43,018
Next
